05.27.25 -- Product Showcase: Advancing Your Molecule With Speed And Agility

We offer a comprehensive suite of bioanalytical and spatial biology solutions designed to support the progression of your molecule from discovery through clinical development and product approval.

With our scale and experience in both chemistry and biologics, Curia is uniquely positioned to provide mRNA drug development solutions.

Sterile Capillary Units (SCUs) are disposable, pre-sterilized filtration devices with PES or Hydrosart® membranes, offering stability, and optimized performance.

FlexFactory biomanufacturing process trains can help scientists better control the production and processing of different viral vectors and new modalities. Plan your agile manufacturing strategy with greater efficiency and integration to address current and future capacity needs.

Unlock automated, precise biomolecular structure measurements from a single drop. Gain cleaner, faster, more critical insights into your biomolecules with this innovative solution.

Uncover how we were able to efficiently activate the site and enroll 130 participants within six months, demonstrating our expertise in clinical trial management.

Battelle’s HIT SCAN platform accelerates gene therapy by using high-throughput methods to design, screen, and optimize polymer nanoparticles (PNPs) for effective, non-viral delivery.

Discover the unparalleled flexibility and automation that sets the IJM NanoScaler Pro apart from other lipid nanoparticle systems.

Meet your mRNA product's specific needs with assay packages that provide the product and process knowledge needed to develop a quality target product profile and identify critical quality attributes.

Ensure the safety and efficacy of your mRNA therapeutics with high-quality, GMP-grade reagents from a trusted partner with a multi-tiered quality approach to deliver manufacturing certainty.

You can quickly and easily accomplish sample QC using Agilent automated electrophoresis solutions. These solutions help provide reliable sample quality control outcomes during the development and production of DNA- and RNA-based vaccines.

By combining disruptive technology platforms with unparalleled genomic medicine development expertise, we're positioned to accelerate the development of LNP formulations and drug products.

Transition from early-phase research through process development into the clinic with these continuum sgRNA available in different grades.

Discover how revolutionary and environmentally sustainable nanoparticle technologies coupled with innovative formulation approaches can address drug solubility issues and add value for patients.

Make use of our portfolio of raw materials required for mRNA with an integrated offering for all process steps, from plasmid DNA (pDNA) to mRNA synthesis to final formulation.

One Team, One Roof, One CDMO

ReciBioPharm’s expanded biologics services and technologies encompass the entire RNA development and manufacturing value chain, helping to deliver your innovation to patients seamlessly.

Meet our OligoProcess oligonucleotide synthesizer – exceptional scale ranges in 3 different scale designs to fit your needs up to 1800 mmol and beyond.